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A B S T R A C T
Haematopoiesis, the process of blood production, occurs from a tiny contingent of haematopoietic stem cells
(HSC) in highly specialised three-dimensional niches located within the bone marrow. When haematopoiesis is
replicated using in vitro two-dimensional culture, HSCs rapidly diﬀerentiate, limiting self-renewal. Emulsion-
templated highly porous polyHIPE foam scaﬀolds were chosen to mimic the honeycomb architecture of human
bone. The unmodiﬁed polyHIPE material supports haematopoietic stem and progenitor cell (HSPC) culture, with
successful culture of erythroid progenitors and neutrophils within the scaﬀolds. Using erythroid culture meth-
odology, the CD34+ population was maintained for 28 days with continual release of erythroid progenitors.
These cells are shown to spontaneously repopulate the scaﬀolds, and the accumulated egress can be expanded
and grown at large scale to reticulocytes. We next show that the polyHIPE scaﬀolds can be successfully func-
tionalised using activated BM(PEG)2 (1,8-bismaleimido-diethyleneglycol) and then a Jagged-1 peptide attached
in an attempt to facilitate notch signalling. Although Jagged-1 peptide had no detectable eﬀect, the BM(PEG)2
alone signiﬁcantly increased cell egress when compared to controls, without depleting the scaﬀold population.
This work highlights polyHIPE as a novel functionalisable material for mimicking the bone marrow, and also
that PEG can inﬂuence HSPC behaviour within scaﬀolds.
1. Introduction
Most if not all cells in the body reside in a 3D environment where an
array of cell signals, extracellular matrix, cytokine and chemokine
signalling are likely presented simultaneously and are tightly regulated.
The bone marrow is an example of such a complex 3D environment,
where the human body eﬃciently compartmentalises the multi-stage
process of haematopoiesis. Here, normal blood production occurs
continually at an impressive rate, using only a tiny contingent of hae-
matopoietic stem cells for an individual's entire lifetime. This contrasts
to current state of the art planar two-dimensional (2D) liquid cultures,
where the process of erythropoiesis is routinely replicated in a labora-
tory setting using culture systems that have been optimised over 15–20
years. To date, 2D culture systems have generated a dose of 2.5 mL
packed reticulocytes to provide a proof of principal autologous trans-
fusion into a single patient [1] and more recently stirrer ﬂask cultures
have generated 10mL volume of leukoﬁltered packed reticulocytes [2].
Although the cell numbers produced by erythroid 2D cultures are im-
pressive, nutrients, cytokines and growth factors are provided in excess
and in a relatively uncontrolled fashion, reducing cellular expansion
potential. These limitations to the current 2D culture process mean that
the manufacture of a standard adult therapeutic dose in the region of
2× 1012 cRBCs remains an extensive bioengineering and logistical
challenge.
A wide range of materials have been utilised for the engineering of
biomimetic materials for 3D culture of haematopoietic lineages to try
and better reﬂect the in vivo situation, with examples including; poly-
urethane (PU) [3–6], ﬁbrin [7], bio-derived bone [8], poly(ethylene
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terephthalate (PET) [9], non-woven polyester disks [10], hollow ﬁbres
[11] and also the incorporation of hydrogels either alone or in combi-
nation with other porous scaﬀold materials [12–16]. As well as oﬀering
the potential to compartmentalise cell proliferation and diﬀerentiation
and control cellular growth signals, scaﬀold cultures have a range of
additional potential beneﬁts over 2D culture, including the reduction of
media volumes via an increase in surface area and a reduction in the use
of cytokines if scaﬀolds are biomimetic, both of which would oﬀer a
reduction in costs. In addition, 3D cultures have the potential for self-
perpetuation of stem cells by more accurate control of growth factors
and stimuli and also an accompanied reduction in labour requirements
(as discussed in Ref. [17]). The successful biomimicry of the bone
marrow niche using scaﬀold cultures would oﬀer a wide range of po-
tential uses, including tissue engineering for blood production, models
systems for fundamental stem cell research on steady state haemato-
poiesis and haematopoietic disease, in addition to medical applications
such as HSC expansion for transplants and as a drug screening platform.
We have previously shown successful biocompatibility and culture
of adult CD34+ haematopoietic stem and progenitor cells (HSPCs) in
PU scaﬀolds but this scaﬀold system was largely exhausted after 28
days of continued culture and egress [6]. We now describe a second-
generation scaﬀold based culture system employing a thiol-containing
biomimetic polyHIPE scaﬀold to enable functionalisation of the mate-
rial surface for ex vivo expansion of HSPCs. Polymerised high internal
phase emulsions (polyHIPEs) are produced by emulsion templating
whereby the continuous, oil-based phase of the emulsion is polymerised
in the presence of the aqueous phase droplets, yielding a highly porous
solid foam material [18–23]. The scaﬀold type was switched from PU to
polyHIPE for two reasons; 1) polyHIPEs can be prepared with pendant
thiol (-SH) functionality allowing easy attachment of molecules of in-
terest; and 2) polyHIPE scaﬀolds currently have proven biocompat-
ibility and performance in a range of in vitro 3D cell culture systems
including; osteoblasts [24,25], HepG2 liver cells [26], neurons [27,28],
adipocyte derived stem cells [29], neural progenitor cells [30] and
primary human endometrial cells [31]. The successful biomimicry of
the bone marrow niche microenvironment would facilitate sustain-
ability and maintenance of the stem cell pool; ultimately increasing the
retention and expansion of the seeded CD34+ population. Functiona-
lisation of scaﬀold materials oﬀers a means of presenting cells with
absent niche signals not currently provided ex vivo. PolyHIPE scaﬀolds
have successfully demonstrated eﬃcacy of surface functionalisation
with galactose and acrylic acid for the culture of hepatocytes [32,33].
More recently polyHIPE scaﬀolds have been functionalised with ﬁ-
bronectin to enhance adhesion of human endometrial cells to scaﬀold
materials [34].
This study describes for the ﬁrst time, the utility of a polyHIPE
scaﬀold material for prolonged haematopoietic stem and progenitor cell
(HSPC) culture. We demonstrate retention of HSPCs for 28 days within
the compartmentalised scaﬀold but also continuous egress and re-
occupation. The accumulated cell egress from the polyHIPE scaﬀolds
can also act as a seed for erythroid large-scale liquid cultures, producing
signiﬁcant numbers of reticulocytes. We then explore the post-poly-
merisation functionalisation of the polyHIPE scaﬀold using a BM(PEG)2
linker and peptide. Although we did not observe any eﬀect of the
speciﬁc peptide used, we did observe a proliferative eﬀect of the BM
(PEG)2 linker, illustrating it is possible to increase output further via
PEG functionalisation whilst still retaining proliferative cells within the
scaﬀold. Therefore, porous polyHIPE scaﬀolds represent an exciting
novel system for potentiation of a compartmentalised haematopoietic
seed culture, and their ease of functionalisation provides the foundation
for biomimicry of the bone marrow niche.
2. Results
2.1. Properties of polyHIPE scaﬀold material
Scaﬀold fabrication is described in detail within the materials and
methods. Brieﬂy, scaﬀolds were prepared using a HIPE oil phase, con-
sisting primarily of dipentaerythritol penta-/hexa-acrylate (DPEHA)
and trimethylolpropane tris(3-mercaptopropionate), producing an
inter-connected, compartmentalised foam-like scaﬀold with a structure
resembling that of human bone (Fig. 1a). PolyHIPE scaﬀolds with a
dimension of 0.5 cm by 0.5 cm cubed were found to have a nominal
porosity of between 80 and 90% and average pore diameters ranging
from 10 to 130 μm (Supplemental Fig. 1c). The scaﬀolds produced for
this study therefore had an average pore diameter of 37 ± 19 μm
[31,35–37].
Compression tests were performed and the resulting stress-strain
curves were produced (Supplemental Fig. 1a). Materials displaying
classical rigid foam behaviour have curves with an initial linear elastic
region followed by a plateau. At small strains, usually less than ca. 10%,
the linear elastic region has a slope equal to the compression (Young's)
modulus. At higher loads, the foam cells (voids) begin to collapse under
the applied load giving a stress plateau. The compressive Young's
moduli values for the unfunctionalised polyHIPE materials were found
to be 13.85 ± 7.13 KPa (Supplemental Fig. 1b) and were able to re-
cover their original dimensions after compression.
2.2. Utilising polyHIPE scaﬀolds for the expansion of haematopoietic
lineages
The use of these scaﬀolds for the ex vivo culture of a range of hae-
matopoietic lineages was explored via directed diﬀerentiation towards
the erythroid, macrophage and neutrophil lineages, in addition to bone
marrow-derived mesenchymal stem cells (MSCs, as previously de-
scribed [38]) (Supplemental Fig. 2). The scaﬀolds were sectioned to
determine internal cellular occupation, this showed erythroid and
neutrophil suspension cultures had a propensity to grow and
Fig. 1. Demonstration that polyHIPE scaﬀolds mimic the human bone
marrow honeycomb architecture. A) Scanning electron micrographs (SEM)
of polyHIPE scaﬀolds at a range of magniﬁcations including 41× (top left),
107× (top right), 180× (bottom left) and 288× (bottom right). Scale bars for
images are as follows; 41× (1mm), 107× (500 μm), 180× (300 μm), 288×
(200 μm). B) Photograph of polyHIPE scaﬀolds (5 mm×5 mm) being moved
into a fresh well of media.
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diﬀerentiate from the CD34+ cells seeded within the material. Occu-
pation of the scaﬀold was also increased in the polyHIPE structure after
28 days compared to our previously published work culturing erythroid
lineage cells in PU scaﬀolds; where distribution and population was
sparse in comparison (Supplemental Figs. 3d and 6). In contrast CD14+
selected macrophage cultures remained on the seeding surface with
sparse and superﬁcial population of the material. Bone marrow MSCs
also largely remained on the seeding edge of the scaﬀold.
2.3. PolyHIPE scaﬀolds for the long-term culture of the erythroid lineage
Next, we focused on the ability of the scaﬀolds to support HSC and
erythroid lineage growth. Scaﬀolds were seeded statically, as described
previously [6] using 0.5×106 CD34+ cells isolated from adult per-
ipheral blood mononuclear cells (PBMNCs) and maintained in serum-
free expansion medium for 28 days. Complete media changes were
carried out every second day by carefully moving the scaﬀold into a
fresh well of media (Fig. 1b). The number of cells that exited the
scaﬀold into the surrounding medium, termed the cell egress, was used
as a measure of the scaﬀold capacity to support proliferation. This re-
vealed an average peak of cell production at day 14 (4.57× 105 cells)
and a total of 2.85×106 cells egressed on average for the entire cul-
ture period (Fig. 2a). Supplemental Fig. 3 provides images for com-
parison to our previously published scaﬀold culture using PU scaﬀolds
and the current polyHIPE scaﬀolds [6]. Cell egress across 28 days is
comparable with polyHIPE cultures peaking on day 14, which is 4 days
later than PU cultures, although total cell egress is comparable
(Supplemental Fig. 3a and b). Cell death for polyHIPE cultures was
reduced across the culture period compared to PU cultures demon-
strating favourable conditions for cell proliferation (Supplemental
Fig. 3c).
When cell egress populations were assessed using a ﬂow cytometry
surface marker panel developed previously [6], there was a persistence
of CD34+ cells throughout the culture, albeit decreasing in population
size and mean ﬂuorescence intensity (MFI) post day 8 of culture and
progressively towards the culture endpoint (Fig. 2b and Supplemental
Fig. 5). A prominent and increasing CD36 expression proﬁle was ob-
served, indicative of megakaryocyte and erythroid progenitors (MEPs)
and early erythroid progenitors [39–41]. Whilst a CD34+/CD36+ cell
represents an MEP a CD34+/CD36- expressing cell is indicative of a less
committed stem cell; as expected there is a large CD34+/CD36- popu-
lation early in the culture which then decreases, however interestingly
Fig. 2. PolyHIPE scaﬀold cultures are able to progress for 28 days where a large proportion are early erythroid progenitors. A) Cellular egress every second
day from control polyHIPE cultures over a 28-day period. Cells counts were conducted using the MACSQuant ﬂow cytometer with automated addition of propidium
iodide to exclude dead cells. B) Flow cytometry analysis on egress from polyHIPE cultures were assessed every 4 days using the MACSQuant ﬂow cytometer with
antibodies to detect the following populations; CD14 (FITC), CD34 (VioBlue), CD36 (PE), CD61 (APC-Vio770) and GPA (APC) as a single ﬂow cytometry panel.
Cellular populations are shown as a percentage of the total live cell population. C) Expression of CD44 and CD34 throughout the polyHIPE scaﬀold culture period.
Scaﬀolds were embedded in paraﬃn and 10 μm sections cut from approximately the middle of the scaﬀold at days 7 (top), 14 (middle) and 28 (bottom) of the culture.
A CD34 (BirmaK3) or CD44 (Bric 235) antibodies were applied to sections neat or IgG1 control and then coupled to Alexa 647 donkey anti-mouse secondary antibody
(displayed in white in the images); DAPI was used to stain the nucleus. Inlays highlight CD34+ expression within the scaﬀolds. D) GPA expression at the edge or
centre of the scaﬀold, GPA (Bric 256) was used to stain scaﬀold sections at day 28 of culture. Images were captured using the 60× lens, all scale bars are 30 μm.
N=4 in triplicate, error bars represent the standard error of the mean.
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there was a second wave of CD34+/CD36- generated around day 20 of
culture (Supplemental Fig. 5d). In comparison to CD36, the increase in
glycophorin A (GPA) expression was more moderate both in terms of
percentage population and MFI, conﬁrming that cell egress population
represents early erythroid progenitors (Fig. 2b and Supplemental
Fig. 5). CD61 expression in scaﬀold egress cells remains moderate but
consistent throughout the culture suggesting that scaﬀolds enable
maintenance of an early stage of lineage commitment and diﬀerentia-
tion (Fig. 2b) [42–45]. Finally, CD14 was also included to detect
monocytes and macrophages however this population remained largely
absent.
Scaﬀolds were also ﬁxed, embedded in paraﬃn wax, sectioned on
the indicated days of culture and probed with lineage markers (Fig. 2c
and d). Using CD44, a pan haematopoietic marker, expression was
observed throughout the structure revealing full penetration and po-
pulation of the material. CD34 was also present, demonstrating the
retention of the seeded population and also conﬁrming the ﬂow cyto-
metry data that expression reduces whilst persisting until the culture
endpoint. Interestingly, a large proportion of the internal cell popula-
tion was observed to reside at the edge of the scaﬀold highly expressing
GPA (Fig. 2d). Taken together, these data suggest that the scaﬀold is
acting to selectively to retain certain populations of HSCs allowing the
persistence and continued proliferation of the culture, albeit through
unknown mechanisms at present. Importantly, the population of the
polyHIPE scaﬀold was considerably increased over our ﬁrst-generation
PU scaﬀold particularly at the edges; therefore, demonstrating a pro-
pensity for the material to retain HSPCs (Supplemental Fig. 3d).
2.4. PolyHIPE scaﬀolds oﬀer a favourable three-dimensional environment
To further investigate the observation of the higher cell density at
the very edge of scaﬀold, we ﬁrst explored the behaviour of cells in
scaﬀolds after seeding with CD34+ cells as above and then imaged over
3 days to visualise cell egress. Targeted locations in the well plate were
repeatedly imaged using the Incucyte Zoom imagining system. This
revealed that cells exit and accumulate in areas surrounding the scaf-
fold (Supplemental Fig. 6a), in addition Supplemental Fig. 6b demon-
strates the cells accumulate around the scaﬀold over a 3-day period.
This raised the question of whether egressed cells also re-enter the
scaﬀold between full media changes. To test this, an experiment using
an empty “follow on” scaﬀold was devised (Fig. 3a). Control scaﬀolds
were seeded as described above and moved to a new well of media
every two days, a second empty scaﬀold was placed into this media
vacated by the ﬁrst scaﬀold which contained the egressed cells. This
process continued for a total of 16 days. Quantiﬁcation of internal cell
populations either at the centre or the edge of the scaﬀold demon-
strated that the scaﬀolds oﬀer an environment favourable to cells
compared to medium. However, perhaps unsurprisingly, the diﬀerence
in cellular abundance between seeded and originally non-seeded scaf-
folds was found to be signiﬁcant (P=≤ 0.05) and highly signiﬁcant
(P=≤ 0.0001) for the centre and edge of the scaﬀold respectively
(Fig. 3b and c). Therefore, the repopulation of empty scaﬀolds suggests
the polyHIPE material is oﬀering a favourable environment over liquid
culture.
We next hypothesised that proteins from the media were being
adsorbed onto the surface of polyHIPE scaﬀolds and subsequently
presented to cells. Proteomic assessment of proteins attached to the
surface of the material during the equilibration step (containing 10%
FCS) revealed 348 proteins across 3 repeats after multiple stringent
washes with a boric acid buﬀer. When the data was analysed for re-
lative abundance the top 20 proteins are displayed in Fig. 3d and in-
clude; haemoglobin, serotransferrin, transferrin and thrombospondin.
2.5. Cell egress can be expanded and grown at scale
To understand the proliferative potential of scaﬀold cultures,
cumulative cell egress was grown in a traditional 2D liquid culture
using spinner ﬂasks. To initiate these cultures a single scaﬀold was
seeded as above, placed within a ﬁnal volume of 40mL of serum free
media in a static tissue culture ﬂask and then incubated for 14 days.
Total scaﬀold egress on day 14 was transferred to a spinner ﬂask in
medium to support erythroid diﬀerentiation (Fig. 4a). On day 14 cells
were largely CD36+GPA+ erythroid progenitors with little CD34 per-
sisting when assessed using ﬂow cytometry (Fig. 4b). When expanded
and diﬀerentiated in spinner ﬂasks for a further 12 days, a total of
(2.59 ± 0.212) × 109 cells were grown from the egress of a single
scaﬀold. This post-scaﬀold expansion generated a total fold increase of
5.18×103 from the initial seeded material. Upon ﬁltration with a
leukoﬁlter removing nuclei and nucleated cells, a total of
(4.21 ± 0.344) × 108 reticulocytes remained (Fig. 4c). The deform-
ability of the reticulocytes produced was tested using an automated
rheoscope and cell analyser (ARCA) [46]. In comparison to mature RBC
the reticulocyte product deformability was remarkably similar, al-
though as expected the spinner ﬂask reticulocytes had a larger area
than the RBCs (Fig. 4d and Supplemental Fig. 7) consistent with their
being reticulocytes rather than mature RBCs. Preliminary data suggests
that additional expansion from the scaﬀold culture cells that egress
between 14 and 28 days is possible, albeit with a lower reticulocyte
yield (data not shown).
2.6. Functionalisation of polyHIPE scaﬀolds using a BM(PEG)2 linker
Thiol-acrylate polyHIPE materials with residual free thiols on the
surface were ﬁrst reacted with BM(PEG)2, forming a stable thio-ether
bond at one end [36,47]. The other end can then act as a handle for
subsequent reactions with cysteine-containing moieties, providing a
facile route to post-polymerisation surface functionalisation, in this case
with Jagged-1 peptides (reported previously [48]) which possess three
cysteine residues (schematic, Fig. 5a). Functionalisation of polyHIPE
scaﬀolds with BM(PEG)2 and Jagged-1 peptide was monitored using x-
ray photoelectron spectroscopy (XPS) to determine the atomic surface
composition (Fig. 5b and Supplemental Fig. 8d). The survey spectra of
BM(PEG)2 and Jagged-1 peptide-functionalised scaﬀolds display N1s
peaks at ca. 399 eV, whereas the unfunctionalised scaﬀold had no peaks
in the N1s region, as expected (Supplemental Fig. 8a–c). The high-re-
solution N1s spectra displayed an increase in nitrogen peak intensity
when Jagged-1 peptide was covalently attached to the BM(PEG)2-
functionalised scaﬀolds, conﬁrming successful functionalisation (Fig. 5c
and d). The second component observed in the N1s spectra at ca. 402
eV is believed to be due to the limited quaternisation side reactions of
amine/amide functionalities during the functionalisation reaction.
The eﬀect of functionalisation on the rigidity of the material was
tested using Young's Modulus. BM(PEG)2 functionalised scaﬀolds gave a
Young's modulus of 44.03 ± 24.45 KPa compared to control scaﬀolds
of 13.85 ± 7.13 KPa (Supplemental Fig. 1b). Therefore, the BM(PEG)2
functionalisation signiﬁcantly (P =<0.05) increased the rigidity of
the material and showed irreversible deformation. On the other hand,
the unfunctionalised material is relatively ﬂexible and could recover
almost completely after compression, retaining their original dimen-
sions.
2.7. Functionalisation of scaﬀolds with BM(PEG)2 increases cell egress
compared to controls
To test for the eﬀect of functionalisation on cell egress, four dif-
ferent scaﬀolds were used; a control scaﬀold, BM(PEG)2 functionalised
scaﬀold, Jagged-1 peptide functionalised scaﬀold and a scrambled
Jagged-1 peptide functionalised scaﬀold. Cell egress was assessed over
20 days from control, Jagged-1 and scrambled Jagged-1 scaﬀolds and
all were found to be comparable. In contrast BM(PEG)2 functionalised
scaﬀolds demonstrated a signiﬁcant increase in overall scaﬀold egress
between days 6 and 12, where for example on day 12 the average cell
C.E. Severn, et al. Biomaterials 225 (2019) 119533
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egress for BM(PEG)2 scaﬀolds were 5.43× 105 and 1.92× 105 for
control scaﬀolds. When assessed as total cell egress across the entire
culture this diﬀerence was highly signiﬁcant (P=<0.001, Fig. 6a and
b) when compared to control scaﬀolds. It should be noted here that the
control scaﬀolds presented alongside functionalisation data were pro-
duced separately to those in Fig. 2, possibly explaining diﬀerences in
cell egress. Diﬀerences in cell surface expression in populations over the
culture period between the scaﬀolds was minimal, suggesting that BM
Fig. 4. PolyHIPE cultures can be used as a starter for large-scale liquid cultures. A) Photographs of the scaﬀold culture and then spinner ﬂask culture. B) Flow
cytometry analysis on egress from polyHIPE cultures were assessed on day 14 before transition to the spinner ﬂask using the MACSQuant ﬂow cytometer with
antibodies to detect the following populations; CD14 (FITC), CD34 (VioBlue), CD36 (PE), CD61 (APC-Vio770) and GPA (APC). Cellular populations are shown as a
percentage of the total live cell population, dead cells were excluded using propidium iodide. C) Cytospin images of cells pre and post leukoﬁltration. Cells were
cytospun onto slides and stained with May-Grünwald's and Giemsa stains before viewing. D) Comparison of size (x-axis) and deformability (y-axis) for control native
RBCs (in red) and cultured reticulocytes (in blue). N= 3, error bars represent the standard error of the mean. (For interpretation of the references to colour in this
ﬁgure legend, the reader is referred to the Web version of this article.)
Fig. 5. Functionalisation of polyHIPE scaﬀolds using BM(PEG)2, successful functionalisation assessed using XPS. A) Schematic representation of the surface
functionalisation of polyHIPE scaﬀolds. B) Atomic composition of N1s from XPS data of polyHIPE scaﬀolds. Atomic percentages are accurate to± 2%. XPS high-
resolution peak-ﬁtted N 1s spectra for c) BM(PEG)2 and d) Jagged-1 peptide functionalised polyHIPE scaﬀolds. Component 1 (red) amide/imide, component 2 (blue)
quaternary amine/amide/imide (N+R4). (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the Web version of this article.)
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(PEG)2 or peptide attachment did not alter cell lineage commitment and
diﬀerentiation in scaﬀold cell egress (Fig. 6c–f). The expected increase
in the CD34+ population in the Jagged-1 scaﬀolds over controls was
not observed and cell populations within the scaﬀold were also com-
parable upon immunoﬂuorescence labelling of scaﬀold sections using
CD34 and GPA as markers (Supplemental Fig. 9).
3. Discussion
This study has shown the propensity of polyHIPE scaﬀolds to mimic
the compartmentalisation observed in honeycomb structures of the
bone marrow and their biocompatibility for prolonged ex vivo culture of
HSCs. Unlike our previously reported PU based scaﬀolds [6] we have
demonstrated that the HSPCs still occupy the scaﬀolds extensively after
28 days of culture, whereas the PU based scaﬀolds are mostly exhausted
by this stage of culture. The scaﬀolds utilised here for HSPC cultures
perform best with CD34+ derived erythroid and neutrophil cultures,
whereas adherent cells such as macrophages and MSCs did not persist
within the scaﬀold in its current design. Scaﬀold occupation was par-
ticularly favourable for erythroid cultures with CD34+ cells prolifera-
tion potential remaining within the scaﬀold and also egress from each
individual 0.5 cm3 scaﬀold persisting for the 28 days of culture. For the
ﬁrst time we also show that with this material the cells that egress do
not simply just remain outside of the scaﬀold but re-enter the scaﬀolds,
populating the edges and also deeper within the scaﬀolds, demon-
strating an attraction of cells to the material. Proteomic studies found
that protein adsorption from the media equilibration step occurs onto
polyHIPE scaﬀolds, which may also enhance the scaﬀolds attraction for
certain cell types such as HSPCs.
We show that the erythroid progenitors that spontaneously exit
polyHIPE scaﬀolds are highly proliferative, with an average of a
5.18×103 fold increase in total cell number generated in post scaﬀold
liquid culture. This demonstrable capacity for scaﬀolds to successfully
seed larger scale liquid culture systems whilst still retaining an internal
population, is a unique and novel beneﬁt of the protocol and system as
a whole. Although not described in this work an additional 2-week
period of expansion from scaﬀold egress was also possible but pro-
liferative capacity of the egressed cells reduced with continued culture.
Further optimisation work would be required to ensure cells are cor-
rectly maintained in the appropriate media to match the diﬀerentiation
stage, oﬀering potential to further improve the reticulocyte yield and
proliferation achieved by the cells that egress later. This preliminary
scale-up data also demonstrates the exciting versatility and potential of
the scaﬀold system should self-renewal be induced further by functio-
nalisation.
True ex vivo biomimicry requires scaﬀolds to be functionalised,
presenting absent in vivo signals, aiding in proliferation or facilitation of
a cellular phenotype. In an attempt to increase the proliferation of
CD34+ cells within polyHIPE scaﬀolds used here, we presented absent
bone marrow niche signals using the notch signalling pathway by
functionalising scaﬀolds with Jagged1 peptides via a BM(PEG)2 linker.
There is current evidence of notch signalling to support and increase the
self-renewal of CD34+ cells and HSPCs in vitro in 2D and 3D culture
systems. Lee et al. has provided evidence for the use of Jagged-1 ligand
for the expansion of HSCs and production of T cells using a layer by
layer surface modiﬁcation method on inverted colloidal crystal scaf-
folds [49]. Further work by Benveniste demonstrated CD34+ cell ex-
pansion in vitro was also supported by OP-9 cells expressing delta like-4
notch ligand, although notch signalling was not a requirement in the in
vivo experiments [50]. More recently delta-1 ligand has been im-
mobilised on microparticles in stirred bioreactors to increase progenitor
cell numbers [51] and incorporated into PEG containing hydrogels for
the expansion of umbilical cord CD34+ derived T cells [52]. Un-
fortunately, in our system the Jagged-1 peptide used did not oﬀer a
signiﬁcant increase in cell egress nor an elevated CD34+ scaﬀold po-
pulation when compared to control cultures. One explanation could be
that the peptide is presented in a non-bioactive manner, as there are 3
cysteine residues in the peptide, any of which could react with the BM
(PEG)2. Therefore, the peptide is likely to be presented in multiple or-
ientations to the cells. Another explanation is that the peptide itself
does not exert a bio-active enhancement eﬀect in our culture conditions
or when immobilised. In our study Jagged-1 peptide was immobilised
covalently, whereas the original study which published the peptide
sequence used the peptide in solution [48].
Interestingly, the BM(PEG)2 linker alone provided a positive pro-
liferative eﬀect, with signiﬁcantly increased scaﬀold cellular egress
observed compared to the unfunctionalised control scaﬀolds. When the
mechanical behaviour of the scaﬀolds was tested under compression,
the BM(PEG)2 scaﬀolds were signiﬁcantly more rigid compared to un-
functionalised scaﬀolds. The increase in rigidity of the BM(PEG)2
functionalised material, more closely reﬂecting that of the endosteal
niche at 35KPa may account for the diﬀerence in cell behaviour
[53–56]. The response of the scaﬀold population to the change in mi-
crotopography and biomaterial mechanostimulus may encourage the
subsequent proliferation within the cultures [57–59] (reviewed in Refs.
[60,61]). This eﬀect, however, could also be due to BM(PEG)2 func-
tionalisation causing the material to be more hydrophilic thus im-
proving cell migration, medium ﬂow and nutrient exchange. This pro-
liferative eﬀect did not occur when BM(PEG)2 was added into 2D liquid
cultures suggesting that it is not a result of the direct eﬀect of the
molecule (data not shown).
Applications of PEG are versatile and in the past have included
surgical implant coating [62], polymer-based drug delivery [63] and
incorporation into hydrogels for tissue engineering [13–16]. As a result
of such work, PEG has been included in the fabrication or functionali-
sation of hydrogels and scaﬀolds material fabrication for many years
partly owing to its versatile properties [13–16]. Our data therefore
strengthens the evidence for inclusion of PEG in HSC CD34+ scaﬀold
cultures and in particular as a novel scaﬀold modiﬁcation to drive
proliferation.
Although we show here for the ﬁrst-time enhancement of pro-
liferation and egress using PEG functionalisation of polyHIPE scaﬀolds,
a more biomimetic functionalisation of the scaﬀolds would oﬀer a facile
route to increase the complexity of current three-dimensional cultures
and thus ex vivo biomimicry of the bone marrow niche. However, only a
limited degree of biomimetic expansion has been observed previously
and the ﬁeld is still exploring factors that regulate HSCs. To this end, we
are currently screening a peptide library for suitable HSC expansion and
maintenance candidates, before transitioning into the established
scaﬀold model. A culture system that successfully and comprehensibly
recapitulates and mimics the human bone marrow niche would oﬀer
beneﬁts further aﬁeld than simply a seed source for large scale cultures
and the production of reticulocytes for transfusion. Such a system
would have utility as a broad and powerful research tool for exploring
haematopoiesis in health and disease and for therapeutic applications
including for example, the expansion of HSCs for subsequent stem cell
transplantation or drug screening. This study therefore presents
polyHIPE as a novel and functionalisable scaﬀold biomaterial for the
culture and manipulation of HSCs ex vivo.
4. Materials and methods
4.1. Antibodies
Primary antibodies, Bric 235 (CD44 40 μg/mL, IBGRL reagents),
Birma K3 (CD34 40 μg/mL, IBGRL reagents) and Bric 256 (GPA 97 μg/
mL, IBGRL Reagents) were used undiluted on scaﬀold sections.
Conjugated antibodies; CD36, CD61, GPA, CD34 (Miltenyi Biotec)
CD14 (BioLegend) were all used as per manufacturer's instructions.
Alexa Fluor 647 (Invitrogen) was used as a secondary antibody for
immunoﬂuorescence studies at 5 μg/mL.
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4.2. Peripheral blood mononuclear cell and CD34+ cell isolation
Peripheral blood mononuclear cells (PBMNC) were isolated from
platelet apheresis blood waste (NHSBT, Bristol, UK) from healthy do-
nors with informed consent. Ethics approval for all experimental pro-
tocols was granted by Bristol Research Ethics Committee (REC 12/SW/
0199), and all methods were carried out in accordance with approved
guidelines. PBMNC separation was performed using Histopaque® 1077
as described previously [64,65]. CD34+ and CD14+ cells were isolated
from PBMNCs using magnetic activated cell separation (MACS, Miltenyi
Biotec) as previously described and according to manufacturer's in-
structions [65–67].
4.3. Scaﬀold preparation
The preparation of polyHIPE materials by emulsion templating and
photopolymerisation has been previously reported [36]. Brieﬂy, poly-
HIPE scaﬀolds of 90% nominal porosity were prepared as follows: the
HIPE oil phase, consisting dipentaerythritol penta-/hexa-acrylate
(DPEHA; 3.47 g), trimethylolpropane tris(3-mercaptopropionate)
(TMPTMP; 4.84 g), 1,2-dichloroethane (DCE; 7mL), surfactant hy-
permer B246; 0.50 g, and a photoinitiator (a blend of diphenyl(2,4,6-
trimethylbenzoyl)-phosphine oxide and 2-hydroxy-2-methylpropio-
phenone; 0.7 mL) was added to a 2-neck round bottom ﬂask and light
was excluded. An aqueous phase of deionised water (126mL) was then
added dropwise with constant shear (300 rpm) from an overhead stirrer
ﬁtted with a D-shaped PTFE paddle. Once addition of the aqueous phase
was complete, the HIPE was stirred for a further minute in order to
ensure emulsion homogeneity. The HIPE was then poured into a syr-
inge, then added to a (0.5× 0.5×0.5) cm PTFE mould and cured by
passing under a UV irradiator (Fusion UV Systems Inc. Light Hammer 6
variable power UV curing system with LC6E benchtop conveyor), pro-
ducing cubical polyHIPE monoliths. Once cured, the polyHIPE was then
washed by immersion in acetone, followed by Soxhlet extraction in
dichloromethane overnight. The polyHIPE was then dried under re-
duced pressure. The produced polyHIPE material has been shown to
possess residual surface thiols [47]. These thiols can then be used as a
handle to allow post-polymerisation functionalisation with maleimides,
via Michael addition under benign conditions [68]. PolyHIPE scaﬀolds
have the additional beneﬁt that they are manufactured in a mould,
increasing standardisation and therefore the reproducibility between
scaﬀold experiments and also ability for scale-up of the system.
4.4. Compression testing
The mechanical behaviour of polyHIPE materials under compres-
sion was evaluated using a Shimadzu EZ-LX compact table-top uni-
versal tester equipped with a 500 N load cell ﬁtted with compression
plates tested at ambient temperature. The polyHIPE samples were cubes
of 0.5mm in dimension. Compression was continued until a ﬁnal strain
of around 50% was reached. Experiments were repeated using six dif-
ferent samples of each material to obtain average Young's modulus
values.
4.5. Scaﬀold void measurement
Image analysis was carried out using Image J image analysis soft-
ware (version 1.49). Void diameters of 100 voids were measured in a
random walk across the SEM micrograph. A statistical correction factor
is applied to the data in order to account for the underestimation in
void diameter [69].
4.6. Functionalisation with BM(PEG)2
30 cubes of polyHIPE scaﬀolds (ca. 200mg) were placed in a glass
vial containing a solution of BM(PEG)2 (70mg) in 1,2-dichloromethane
(DCM; 20mL). A 100 μL of trimethylamine (TEA) was added and the
mixture was left at ambient temperature for 48 h. The polyHIPE scaf-
folds were washed with DCM (3× 5 mL) and ethanol (3× 5 mL).
4.7. Functionalisation with Jagged-1 peptide
12 cubes of polyHIPE scaﬀolds (ca. 85mg) were placed in a vial
containing a solution of 25mg Jagged-1 peptide, CDDYYYGFGCNKF-
CRPR or jagged control peptide, CRGPDCFDNYGRYKYCF (published
previously [48]) in 50% aqueous ethanol (20mL). 50 μL of TEA was
added and the mixture was left at ambient temperature for 48 h. The
polyHIPE scaﬀolds were ﬁnally washed with ethanol (3× 10 mL).
Jagged-1 amino acid sequence was reordered to produce a scrambled to
use as a peptide control for the addition of a peptide to the scaﬀold.
4.8. X-ray photoelectron spectroscopy
X-Ray photoelectron spectroscopy (XPS) analysis was performed
using a Kratos Axis Ultra DLD spectrometer at the University of
Warwick. The scaﬀolds were cut to suitable size, attached to double
sided carbon tape and mounted onto a stainless-steel bar. The surface
composition of the modiﬁed scaﬀolds was characterised. The data was
subsequently charge corrected using the C–C/C–H peak at 284.6 eV as a
reference. The measurements were conducted at room temperature and
at a take-oﬀ angle of 90° with respect to the surface. Survey spectra
were acquired to determine the elemental composition of the surface.
High-resolution spectra of the principle core level of each element
present were then acquired for chemical state identiﬁcation. Both
survey and core level XPS spectra were recorded from a surface area of
300× 700 μm, with such a large area, it is deemed to be representative
of the whole sample surface. Data were analysed using the Casa XPS
software, using Gaussian–Lorentzian (Voigt) line shapes and Shirley
backgrounds.
4.9. Scaﬀold preparation and equilibration for culture
Scaﬀolds were prepared for culture by transferring to 70% ethanol
and then washed by immersion in phosphate buﬀered saline (PBS) for
20min. Scaﬀolds were centrifuged at 2,000 rpm for 10min before the
removal of PBS and then exposed to ultra violet (UV) radiation for
15min. The PBS was replaced with 70% ethanol for 2 h at room tem-
perature with rotation. Finally, the scaﬀolds were washed twice with
PBS to remove residual ethanol and stored in StemSpan (Stem Cell
Technologies) with 10% foetal calf serum (FCS, Gibco) and penicillin/
streptomycin at 100U/0.1 mg per mL of media respectively (Sigma), for
at least 2 days to equilibrate at 37 °C with 5% CO2.
4.10. Three dimensional erythroid cultures
Scaﬀolds were dried of storage media using sterilised 3MM
Whatman paper and equilibrated to 37 °C until cell seeding. 0.5× 106
CD34+ cells were seeded statically in 20 μl of media, as described
below. The scaﬀolds were then incubated at 37 °C with 5% CO2 for 2 h;
with media added as required to ensure scaﬀolds did not dry out.
1.5 mL of serum free expansion medium culture media consisting of
StemSpan supplemented with; penicillin/streptomycin at 100U/0.1 mg
per mL of media respectively (Sigma), cholesterol-rich lipids 40 μg/mL
(Sigma), stem cell factor 100 ng/mL (SCF, Miltenyi Biotec), Interleukin-
3 1 ng/mL (IL-3, R&D Systems), insulin like growth factor-1 40 ng/mL
(IGF-1, R&D Systems), dexamethasone 1 μM/mL (Dex, Sigma) and er-
ythropoietin 2U/mL (Bristol Royal Inﬁrmary) was gently added to each
scaﬀold. Full medium changes were performed every 2 days by lifting
the scaﬀold with tweezers and moving it to a fresh. The cells that are
left behind in the well are termed the cell egress, as they have spon-
taneously exited the scaﬀold. Scaﬀold egress was counted using the
MACSQuant ﬂow cytometer (Miltenyi Biotec). Cells were auto-labelled
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with propidium iodide (Miltenyi Biotec) at a ﬁnal concentration of
1 μg/mL. Dead cells were excluded, and a live cell count taken as a
density per millilitre.
4.11. Three-dimensional neutrophil, macrophage and MSC cultures
For neutrophil cultures, 0.5× 106 CD34+ cells were isolated and
seeded statically in 20 μl of media as described above. Scaﬀolds were
then cultured in IMDM Biochrom (Merck) as a base media supple-
mented with 10% foetal bovine serum (Gibco), 100 U/mL penicillin
(Sigma) and 100 μg/mL streptomycin (Sigma), 50 ng/mL Stem Cell
Factor (SCF; Miltenyi Biotec), 10 ng/mL IL-3 (R&D Systems), 50 ng/mL
Flt3 ligand (Miltenyi Biotec), 10 ng/mL granulocyte colony stimulating
factor (G-CSF, Miltenyi Biotec) and 10 ng/mL granulocyte-macrophage
colony stimulating factor (GM-CSF, Miltenyi Biotec). Macrophage cul-
tures were seeded with CD14+ cells isolated from PBMNCs as described
above with 0.5× 106 being seeded onto scaﬀolds statically. Scaﬀolds
were maintained in media as described above. MSC cultures were in-
itiated with human bone marrow-derived MSCs isolated via adherence
selection [38]. Cells were maintained in a DMEM (low glucose, Sigma)
base media supplemented with 10% FCS (Gibco), 100 U/mL penicillin
(Sigma) and 100 μg/mL streptomycin (Sigma), Glutamax (1/100) and
10 ng/mL ﬁbroblast growth factor (FGF). Scaﬀolds were cultured with
neutrophils for 16 days, MSCs for 21 days, macrophages for 7 days and
erythroblasts for 28 days.
4.12. Scale up erythroid culture post 3D culture
Erythroid diﬀerentiation post scaﬀold culture was conducted as
previously described [2] and is brieﬂy outlined below. The primary
medium was Iscove's Modiﬁed Dulbecco's Medium (IMDM; Source
BioScience UK Ltd) supplemented with 3U/mL erythropoietin (Epo;
Bristol Royal Inﬁrmary), 3 U/mL heparin (Sigma), 0.5 mg/mL holo-
transferrin (Sigma), 3% (v/v) heat-deactivated Human Male AB Serum
(Sigma), 2 mg/mL Human Serum Albumin (HSA; Sigma), 10 μg/mL
insulin (Sigma), 100 U/mL penicillin (Sigma) and 100 μg/mL strepto-
mycin (Sigma), with extra supplementation of 100 ng/mL Stem Cell
Factor (SCF; Miltenyi Biotec) and 1 ng/mL IL-3 (R&D Systems) to in-
duce cell proliferation. The cells were incubated at 37 °C in 5% CO2 in
this primary medium with daily media addition from Day 3 to Day 7 of
culture. From Day 8 to Day 12, secondary medium was added instead,
which consisted of the same IMDM base supplemented with only
100 ng/mL SCF. After Day 13, tertiary medium consisting of the IMDM
base without growth factor additions was used in order to induce
terminal erythroid diﬀerentiation. On Day 21, reticulocytes were pur-
iﬁed through leukoﬁltration of the culture to remove nuclei and nu-
cleated cells. For leukoﬁltration, a leukocyte reduction ﬁlter (NHSBT,
Filton, Bristol) was pre-soaked and equilibrated with HBSS and the
cultured cell suspension was loaded into the ﬁlter followed by a large
amount of HBSS and allowed to elute by gravity until the ﬂow-through
was clear. The resulting ﬂow-through was then centrifuged at 400 g, RT
for 20min and the pelleted cells were resuspended in Phosphate Buﬀer
Saline supplemented with 1mg/mL Bovine Serum Albumin (BSA;
Sigma) and 2mg/mL glucose (Sigma) (PBSAG).
4.13. Flow cytometry panel
Flow cytometry was performed using 1× 105 cells labelled with
extracellular conjugated antibodies for 30min at 4 °C. Data were col-
lected using a MacsQuant ﬂow cytometer (Miltenyi Biotec) and pro-
cessed using FlowJo Version 10.0.7 as previously described [6]. Re-
presentative raw ﬂow cytometry data and gating strategies can be
found in Supplemental Fig. 4.
4.14. Histology and immunoﬂuorescence
Scaﬀolds were ﬁxed and prepared for immunoﬂuorescence as pre-
viously described [6]. Samples were imaged using a Leica SP5 confocal
microscope using a 60× lens (N.A. 1.4) in the Wolfson Bioimaging
facility, University of Bristol. Scaﬀolds were ﬁxed in 4% paraf-
ormaldehyde for 15–20 hr and washed four times in PBS for 15min.
Scaﬀolds were paraﬃn embedded and sectioned using a Leica RM2125
Microtome into 10 μm sections ﬂoated onto polysine slides (VWR).
Slides were ﬁrst baked at 56 °C for approximately 5 hr and then over-
night at 37 °C. Slides were de-waxed by immersion into Histo-Clear
(National Diagnostics) for 30–45min before rehydration through a
series of graded ethanol. For immunoﬂuorescence, sections were wa-
shed once in PBS before blocking with PBS containing 4% BSA (PBSA)
for 1 hr. Slides were washed 5 times with PBS before incubating with
primary antibody (primary and control antibodies are as stated in ﬁgure
legends) for 1 hr, again washed 5 times with PBS and incubated with
Alexa 647 secondary antibody (Invitrogen) for 1 hr. Slides were washed
5 times in PBS and incubated in DAPI (Thermo Fisher Scientiﬁc, for-
mally Molecular Probes) to identify nuclei for 5min before a further 2
washes. All steps were carried out at room temperature. For coverslips
cells were ﬁxed onto slide using 1% paraformaldehyde for 5min before
permeabilisation in 0.05% Triton (in PBS) for 5min at room tempera-
ture. Coverslips were then washed three times and blocked and stained
with antibodies as above. Finally, coverslips and slides were washed
and mounted using mowiol (Calbiochem). Samples were imaged using a
Leica SP5 confocal microscope using a 63× lens (N.A. 1.4) in the
Wolfson Bioimaging facility, University of Bristol.
4.15. Scanning electron microscopy
Scaﬀolds were cut in half and mounted on a chuck with the centre of
the scaﬀold face up. The samples were coated using an Emitech K575X
sputter coater with a gold/palladium target and viewed with the
Quanta 400FEI Scanning Electron Microscope (SEM) in the Wolfson
Bioimaging facility, University of Bristol.
4.16. Cytospin preparation and staining
To analyse cell morphology 5–10×104 cells were resuspended in
100 μL PBS and cytocentrifuged onto slides at 350 g for 5min (Thermo
Scientiﬁc, Cytospin 4) before ﬁxation in methanol for 15min and
staining with May-Grünwald's (VWR Chemicals) and Giemsa (Merck
Millipore) stains according to manufacturer's instructions.
4.17. ARCA sample preparation and analysis
2×106 cells were diluted in 200 μL of a polyvinylpyrrolidone so-
lution (PVP viscosity 28.1 mPa s; Mechatronics Instruments) and sam-
ples were assessed in an Automated Rheoscope and Cell Analyser
(ARCA) as previously described [46,70]. Deformation index distribu-
tion was measured under shear stress and a minimum of 1500 valid
cells per sample were acquired.
4.18. Statistical analysis
Where appropriate statistical analysis in the form of a Student's t-
test, used to determine the level of signiﬁcance for Fig. 3 and
Supplementary Fig. 1b and a one way ANOVA for Fig. 6b. The following
indicates, * = P ≤ 0.05, ** = P ≤ 0.01, *** = P ≤ 0.001 in all
instances.
4.19. Liquid chromatography mass spectrometry
Scaﬀolds were prepared and equilibrated as described above and
without any cell seeding were taken for mass spectrometry analysis of
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proteins deposited during preparation. Scaﬀolds were then washed 3
times with a boric acid buﬀer (10mM boric acid, 154mM NaCl, 7.2mM
KCl, 1.8mM CaCl2). Scaﬀold sections were then cut into 1mm2 pieces
and resuspended in 50mM TEAB. The samples were reduced with
20mM tris(2-carboxyethyl)phosphine (55 °C for 1 hr) and then alky-
lated using 37.5 mM iodoacetamide (room temperature for 30min.).
The buﬀer was then removed from the scaﬀold pieces and any proteins
which had been released from the scaﬀold during these processing steps
were precipitated using 6 vol of ice-cold acetone (−20 °C, overnight).
Precipitated material was then collected by centrifugation (8000 g for
10min at 4 °C), resuspended in 100 μl of 50 mM TEAB and transferred
back to original scaﬀold pieces. The samples were then digested using
trypsin (2.5 μg, incubated overnight with shaking at 37 °C).
Post digestion, the buﬀer was removed from each scaﬀold and de-
salted using a SepPak cartridge according to the manufacturer's in-
structions (Waters, Milford, Massachusetts, USA). Eluate from the
SepPak cartridge was evaporated to dryness and resuspended in 1%
formic acid prior to analysis by nano-LC MSMS using an Orbitrap
Fusion Tribrid mass spectrometer (Thermo Scientiﬁc). Peptides were
fractionated using an Ultimate 3000 nano-LC system in line with an
Orbitrap Fusion Tribrid mass spectrometer (Thermo Scientiﬁc). In brief,
peptides in 1% (vol/vol) formic acid were injected onto an Acclaim
PepMap C18 nano-trap column (Thermo Scientiﬁc). After washing with
0.5% (vol/vol) acetonitrile 0.1% (vol/vol) formic acid peptides were
resolved on a 250 mm×75 μm Acclaim PepMap C18 reverse phase
analytical column (Thermo Scientiﬁc) over a 150min organic gradient,
using 7 gradient segments (1–6% solvent B over 1min., 6–15% B over
58min., 15–32%B over 58min., 32–40%B over 5min., 40–90%B over
1min., held at 90%B for 6min and then reduced to 1%B over 1min.)
with a ﬂow rate of 300 nl min−1. Solvent A was 0.1% formic acid and
Solvent B was aqueous 80% acetonitrile in 0.1% formic acid. Peptides
were ionised by nano-electrospray ionisation at 2.2 kV using a stainless-
steel emitter with an internal diameter of 30 μm (Thermo Scientiﬁc)
and a capillary temperature of 250 °C.
All spectra were acquired using an Orbitrap Fusion Tribrid mass
spectrometer controlled by Xcalibur 2.0 software (Thermo Scientiﬁc)
and operated in data-dependent acquisition mode. FTMS1 spectra were
collected at a resolution of 120 000 over a scan range (m/z) of
350–1550, with an automatic gain control (AGC) target of 400 000 and
a max injection time of 100ms. The Data Dependent mode was set to
Cycle Time with 3s between master scans. Precursors were ﬁltered
according to charge state (to include charge states 2–7), with mono-
isotopic precursor selection and using an intensity range from 5E3 to
1E20. Previously interrogated precursors were excluded using a dy-
namic window (40s± 10 ppm). The MS2 precursors were isolated with
a quadrupole mass ﬁlter set to a width of 1.6 m/z. ITMS2 spectra were
collected with an AGC target of 5000, max injection time of 50ms and
HCD collision energy of 35%.
The raw data ﬁles were processed using Proteome Discoverer soft-
ware v1.4 (Thermo Scientiﬁc) and searched against the UniProt Human
database (152 927 entries) using the SEQUEST algorithm. Peptide
precursor mass tolerance was set at 10 ppm, and MS/MS tolerance was
set at 0.6Da. Search criteria included carbamidomethylation of cysteine
(+57.0214) as a ﬁxed modiﬁcation and oxidation of methionine
(+15.9949) as a variable modiﬁcation. Searches were performed with
full tryptic digestion and a maximum of 2 missed cleavage events were
allowed. The reverse database search option was enabled, and all
peptide data was ﬁltered to satisfy false discovery rate (FDR) of 5%.
4.20. Incucyte imaging
Scaﬀolds were seeded and cultured as described above. The plate
was then imaged repeatedly at multiple locations per scaﬀold culture
using the Incucyte Zoom system (Essen BioScience, Welwyn Garden
City, UK) every hour at 20× magniﬁcation.
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